quick drugs hankk Flashcards
rapid acting insulin
Lispro, aspart, and glulisine.
long acting insulin
detemir and glargine
Biguanides (metformin)
increases insulin sensitivity lactic acidosis (contraindicated in renal insufficiency)
sulfonyl ureas
1st gen- chlorpropamide, tolbutamide
2nd gen- glimepiride glyburide and glipizide
glipizide associated with hepatotoxicity and glimepiride and glyburide with hypoglyceia because of long action
MOA: closes K+ channel in beta cell leading cell depolarization and insulin release.
first generation disulfuram like effects
weight gain and hypoglycemia
Glitazones/TZDs
pioglitzone rosiglitazone
increases insulin sensitivoty. binds to PPAR-gamma nuclear transcription regulator.
AE: weight gain, edema, hepatotoxicity, heart failure and increases risk of fracture.
meglitinides
nateglinide, repaglinide.
bind to K+ channel in beta cell increasing insulin release.
AE: hypoglycemia and weight gain.
GLP-1 analogs
exenatide liraglutide.
AE: pancreatitis, modest weight loss
DPP-4 inhibitors
linagliptin, saxagliptin, sitagliptin
AE: mild urinary or respiratory infections.
amylin analogs
pramlinitide.
MOA: decrease gastric emptying and decrease glucagon.
hypoglycemia and nausea.
SGLT-2 inhibitors
canagliflozin, dapagliflozin, and empagliflozin.
block reabsorption of glucose in PCT.
AE: glucosuria, UTIs, vaginal yeast infections, hyperkalemia, dehydration.
alpha glusidase inhibitors
acarbose, miglitol
inhibit intestinal brush border alpha glucosidases.
propylthiouracil (thionamides)
block thyoid peroxidase, inhibiting oxidation of iodide and organification of iodine. (methimazole also).
PTU also inhibits 5’-deiodinase decreasing peripheral conversion of T4 to T3.
demeocycline
ADH antogonist.
member of tetracycline family.
fludricortisone
synthetic analog of aldosterone
AE: worsens HF and leads to hyperpigmentation.
H2 blockers
cimentidine, ranitidine, famotidine, nizatidine.
reversible block of H2 receptor.
cimentidine is also a potent blocker of the CYP450 system. also has antoandrogenic effects(prolactin release), gynecomastia, impotence, decreased libido.
both ranitidine and cimentidine decrease renal excretion of creatinine.
PPIs
irreversibly inhibit H+/K+ ATPase.
AE: increase risk of C diff infection, pneumonia, decreases serum Mg2+ with long term use, osteoporotic hip fractures
aluminum hydroxide
constipation, hyperphosphatemia, prox muscle weakness, osteodystrophy, and seizures.
magnesium hydroxide.
diarrhea, hyporeflexia, hypotension, cardiac arrest.
ondansetron
5-HT3 antagonist.
post op patients and chemo patients.
AE: headache, constipation and QT interval prolongation
memantine
NMDA receptor antagonist (helps prevent exitotoxicity)
used in alzheimer disease
Sumitriptan.
5HT 1B/1D agonist. inhibit trigeminal nerve activation. prevent vasoactive peptide release; induce vasoconstriction
AE: coronary vasospasm (contraindicated in patients with CAD or prinzmetal angina); mild paresthesia.
antipsychotics
Haloperidol, trifluoperazine, thioridazine, chlorpromazine
block D2 receptors.
high potency: trifluoperazine, fluphenazine, and haloperidol
low potency: chlopromazine thioridazine.